Why this matters: Tirzepatide alone already very powerful (15-22%) May already be optimizing GIP/GLP-1 pathways maximally Adding amylin might only add 2-5% more weight loss But could significantly increase side effects Risk-benefit ratio unknown Contrast with CagriSema: CagriSema: Extensively studied, Phase 3 trials, known safety Tirzepatide + cagrilintide: Zero studies, no safety data, speculative Learn about evidence-based approaches at SeekPeptides - explore best peptides for weight loss and best peptide stack for weight loss
The need to use combination therapy, based on fixed-dose combinations (a two-component product in the 1 st step of the therapy and a three-component product in the 2 nd step), and to achieve lower arterial blood pressure values than previously accepted (i.e., 120129/7079 mm Hg) in patients below 65 years of age, should be emphasised [301, 302]
Its NF-kB inhibition operates upstream of the inflammatory cascade
BAC water has benzyl alcohol, whereas sterile solution lacks the same
[Abstract]2024 May 27;14(8):3339-3357
